
11 - 50 employees
Founded 2018
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
Biotechnology • Pharmaceuticals
Belite Bio is a clinical-stage biopharmaceutical company developing novel therapeutics based on its RBP4 (Retinol Binding Protein 4) intellectual property portfolio. Its lead candidate, tinlarebant (LBS-008), is an oral therapy designed to reduce toxic accumulations in the eye and is being developed for retinal degenerative diseases including autosomal recessive Stargardt disease (STGD1) and Geographic Atrophy (advanced dry age-related macular degeneration). Belite Bio is conducting multiple clinical trials (Phase 1b/2, Phase 2/3, and Phase 3 programs such as DRAGON, DRAGON II, and PHOENIX) and tinlarebant has received several regulatory designations (Orphan Drug in US/EU/Japan, Rare Pediatric Disease, Breakthrough Therapy, Fast Track, and Sakigake). The company’s pipeline also includes programs addressing metabolic and liver diseases (e. g. , non-alcoholic fatty liver disease and type 2 diabetes).
🔥 2 minutes ago
Where this job comes from
Posted on Belite Bio's careers page, not through a job board
First seen by Remote Rocketship 2 minutes ago

11 - 50 employees
Founded 2018
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
Biotechnology • Pharmaceuticals
Belite Bio is a clinical-stage biopharmaceutical company developing novel therapeutics based on its RBP4 (Retinol Binding Protein 4) intellectual property portfolio. Its lead candidate, tinlarebant (LBS-008), is an oral therapy designed to reduce toxic accumulations in the eye and is being developed for retinal degenerative diseases including autosomal recessive Stargardt disease (STGD1) and Geographic Atrophy (advanced dry age-related macular degeneration). Belite Bio is conducting multiple clinical trials (Phase 1b/2, Phase 2/3, and Phase 3 programs such as DRAGON, DRAGON II, and PHOENIX) and tinlarebant has received several regulatory designations (Orphan Drug in US/EU/Japan, Rare Pediatric Disease, Breakthrough Therapy, Fast Track, and Sakigake). The company’s pipeline also includes programs addressing metabolic and liver diseases (e. g. , non-alcoholic fatty liver disease and type 2 diabetes).
• Develop and execute patient and consumer marketing strategy to drive disease awareness, patient engagement, brand adoption, and adherence • Own patient-facing promotional activities • Collaborate with agency partners, commercial operations, patient advocacy, medical, legal, regulatory, and access stakeholders • Translate brand strategy into patient experiences across paid, owned, and earned channels • Lead media planning and optimization efforts • Develop integrated patient engagement programs spanning disease awareness, treatment consideration, initiation, adherence, persistence, and advocacy • Use market research, patient insights, analytics, and competitive intelligence to inform strategy and identify growth opportunities • Execute patient-facing campaigns across digital, social, CRM, websites, video, print, and emerging channels • Own media strategy, investment planning, and performance optimization • Oversee the HCP/patient digital ecosystem and omnichannel engagement strategy • Establish KPIs and measurement frameworks to improve campaign effectiveness and business impact • Partner with agencies to deliver compliant marketing programs • Manage marketing budgets, scopes of work, and agency performance • Drive planning, prioritization, governance, and execution • Lead cross-functional collaboration across Patient Advocacy, Commercial Operations, Medical Affairs, Legal/Compliance, and Regulatory functions • Support product launches, lifecycle optimization, and disease awareness efforts • Present actionable updates to senior leadership
• Bachelor's degree required; MBA or advanced degree preferred • Proven success leading omnichannel marketing, media, and non-personal promotion (NPP) strategies • Experience in specialty pharmaceuticals, rare disease, ophthalmology, oncology, immunology, or other specialty therapeutic areas is preferred • Strong understanding of media planning, digital marketing, analytics, and customer engagement • Experience managing agencies, cross-functional teams, and marketing budgets • Product launch and lifecycle management experience preferred • Strong understanding of FDA promotional regulations and industry compliance standards • Excellent project management, organizational, cross-functional collaboration, and communication skills • Must be authorized to work in the United States or obtain appropriate employment authorization
• Annual incentive bonuses • Equity participation • Health insurance • Dental insurance • Vision insurance • 401(k) • Paid time off • Reasonable accommodation for individuals with disabilities
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🔥 9 minutes ago
Marketing and Communications Manager shaping Bluesky's narrative through content, campaigns, launches, and media relations. Building communications for a decentralized social media ecosystem.
🇺🇸 United States – Remote
💵 $148k - $183k / year
⏰ Full Time
🟠 Senior
🔴 Lead
🎡 Marketing
🦅 H1B Visa Sponsor
🔥 16 minutes ago
Director building Apartment List’s renter lifecycle marketing programs across email, push, and SMS. Leading personalization, analytics, partnerships, and a two-person team.
🔥 48 minutes ago
Commercial delivery director driving revenue, marketing, CRM, and growth initiatives for Hard Rock Digital’s online gaming business. Owning complex programs from strategy through measurable commercial impact.
🔥 5 hours ago
Regional marketing director driving customer engagement, pipeline growth, and campaigns across the Americas. Shaping localized marketing strategies for Abcam’s life sciences research solutions.
🔥 5 hours ago
VP of Marketing leading social, brand, content, and campaigns for INVO Fertility. Driving patient engagement, acquisition, and practice growth across fertility-care channels.
🇺🇸 United States – Remote
🔥 Funding within the last year
💰 $50M POST IPO EQUITY on 2026-06
⏰ Full Time
🔴 Lead
🎡 Marketing